322 related articles for article (PubMed ID: 27554197)
1. A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial.
Stain HJ; Bucci S; Baker AL; Carr V; Emsley R; Halpin S; Lewin T; Schall U; Clarke V; Crittenden K; Startup M
Schizophr Res; 2016 Oct; 176(2-3):212-219. PubMed ID: 27554197
[TBL] [Abstract][Full Text] [Related]
2. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
3. Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
[TBL] [Abstract][Full Text] [Related]
4. A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial.
Rietdijk J; Dragt S; Klaassen R; Ising H; Nieman D; Wunderink L; Delespaul P; Cuijpers P; Linszen D; van der Gaag M
Trials; 2010 Mar; 11():30. PubMed ID: 20307268
[TBL] [Abstract][Full Text] [Related]
5. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
[TBL] [Abstract][Full Text] [Related]
6. The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial.
Glenthøj LB; Fagerlund B; Randers L; Hjorthøj CR; Wenneberg C; Krakauer K; Vosgerau A; Gluud C; Medalia A; Roberts DL; Nordentoft M
Trials; 2015 Jan; 16():25. PubMed ID: 25623736
[TBL] [Abstract][Full Text] [Related]
7. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.
Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D
Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial.
Reininghaus U; Klippel A; Steinhart H; Vaessen T; van Nierop M; Viechtbauer W; Batink T; Kasanova Z; van Aubel E; van Winkel R; Marcelis M; van Amelsvoort T; van der Gaag M; de Haan L; Myin-Germeys I
Trials; 2019 Dec; 20(1):769. PubMed ID: 31878966
[TBL] [Abstract][Full Text] [Related]
9. The impact of psychotic experiences in the early stages of mental health problems in young people.
Heinze K; Lin A; Nelson B; Reniers RLEP; Upthegrove R; Clarke L; Roche A; Lowrie A; Wood SJ
BMC Psychiatry; 2018 Jun; 18(1):214. PubMed ID: 29954377
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial.
Ising HK; Smit F; Veling W; Rietdijk J; Dragt S; Klaassen RM; Savelsberg NS; Boonstra N; Nieman DH; Linszen DH; Wunderink L; van der Gaag M
Psychol Med; 2015 May; 45(7):1435-46. PubMed ID: 25330734
[TBL] [Abstract][Full Text] [Related]
11. Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial.
Bucci S; Barrowclough C; Ainsworth J; Morris R; Berry K; Machin M; Emsley R; Lewis S; Edge D; Buchan I; Haddock G
Trials; 2015 Sep; 16():404. PubMed ID: 26357943
[TBL] [Abstract][Full Text] [Related]
12. Mindfulness-based social cognition training (SocialMIND) versus psychoeducational multicomponent intervention for people with a first episode of psychosis: a study protocol for a randomised controlled trial.
Mediavilla R; Muñoz-Sanjose A; Rodriguez-Vega B; Bayon C; Palao A; Lahera G; Sanchez-Castro P; Roman E; Cebolla S; de Diego A; Pastor JM; Bravo-Ortiz MF
BMC Psychiatry; 2019 Jul; 19(1):233. PubMed ID: 31357965
[TBL] [Abstract][Full Text] [Related]
13. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial.
Pot-Kolder RMCA; Geraets CNW; Veling W; van Beilen M; Staring ABP; Gijsman HJ; Delespaul PAEG; van der Gaag M
Lancet Psychiatry; 2018 Mar; 5(3):217-226. PubMed ID: 29429948
[TBL] [Abstract][Full Text] [Related]
14. Treating sleep problems in young people at ultra-high-risk of psychosis: study protocol for a single-blind parallel group randomised controlled feasibility trial (SleepWell).
Waite F; Kabir T; Johns L; Mollison J; Tsiachristas A; Petit A; Černis E; Maughan D; Freeman D
BMJ Open; 2020 Nov; 10(11):e045235. PubMed ID: 33172953
[TBL] [Abstract][Full Text] [Related]
15. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.
Morrison AP; French P; Stewart SL; Birchwood M; Fowler D; Gumley AI; Jones PB; Bentall RP; Lewis SW; Murray GK; Patterson P; Brunet K; Conroy J; Parker S; Reilly T; Byrne R; Davies LM; Dunn G
BMJ; 2012 Apr; 344():e2233. PubMed ID: 22491790
[TBL] [Abstract][Full Text] [Related]
16. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.
McGorry PD; Nelson B; Phillips LJ; Yuen HP; Francey SM; Thampi A; Berger GE; Amminger GP; Simmons MB; Kelly D; Dip G; Thompson AD; Yung AR
J Clin Psychiatry; 2013 Apr; 74(4):349-56. PubMed ID: 23218022
[TBL] [Abstract][Full Text] [Related]
18. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
[TBL] [Abstract][Full Text] [Related]
19. Sources of clinical distress in young people at ultra high risk of psychosis.
Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis.
Addington J; Epstein I; Liu L; French P; Boydell KM; Zipursky RB
Schizophr Res; 2011 Jan; 125(1):54-61. PubMed ID: 21074974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
